<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37556038</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-6903</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Neurochemical research</Title><ISOAbbreviation>Neurochem Res</ISOAbbreviation></Journal><ArticleTitle>An Increase in Peroxiredoxin 6 Expression Induces Neurotoxic A1 Astrocytes in the Lumbar Spinal Cord of Amyotrophic Lateral Sclerosis Mice Model.</ArticleTitle><Pagination><StartPage>3571</StartPage><EndPage>3584</EndPage><MedlinePgn>3571-3584</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11064-023-04003-w</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease with selective degeneration of motor neurons. It has been reported that an increase in the levels of inflammatory cytokines and glial cells such as reactive astrocytes is closely involved in the pathological progression of ALS. Recently, the levels of neuropathic cytotoxic (A1) astrocytes among reactive astrocytes have reportedly increased in the central nervous system of ALS mice, which induce motor neuron degeneration through the production of inflammatory cytokines and secretion of neuropathic factors. Hence, elucidating the induction mechanism of A1 astrocytes in ALS is important to understand the mechanism of disease progression in ALS. In this study, we observed that the expression of peroxiredoxin 6 (PRDX6), a member of the peroxiredoxin family, was markedly upregulated in astrocytes of the lumbar spinal cord of SOD1<sup>G93A</sup> mice model for ALS. Additionally, when PRDX6 was transiently transfected into the mouse astrocyte cell line C8-D1A and human astrocytoma cell line U-251 MG, the mRNA expression of complement C3 (a marker for A1 astrocyte phenotype) and inflammatory cytokines was increased. Furthermore, the mRNA expression of C3 and inflammatory cytokine was increased in C8-D1A and U-251 MG cells stably expressing PRDX6, and the increased mRNA expression was significantly suppressed by MJ33 (lithium[1-hexadecoxy-3-(2,2,2-trifluoroethoxy) propan-2-yl] methyl phosphate), an inhibitor of the phospholipase A<sub>2</sub> activity of PRDX6. Our results suggest that the expression of PRDX6 in astrocytes plays an important role in the induction of A1 astrocytes and expression of inflammatory cytokines in the ALS mice model.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yamamuro-Tanabe</LastName><ForeName>Akiko</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka, 573-0101, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukai</LastName><ForeName>Yurika</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka, 573-0101, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kojima</LastName><ForeName>Wataru</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka, 573-0101, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Siyuan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka, 573-0101, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsumoto</LastName><ForeName>Naoko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka, 573-0101, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takada</LastName><ForeName>Shoho</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka, 573-0101, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mizuhara</LastName><ForeName>Mao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka, 573-0101, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kosuge</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacology, School of Pharmacy, Nihon University, Chiba, 274-8555, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishimaru</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka, 573-0101, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshioka</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka, 573-0101, Japan. yoshioka@pharm.setsunan.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurochem Res</MedlineTA><NlmUniqueID>7613461</NlmUniqueID><ISSNLinking>0364-3190</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.11.1.15</RegistryNumber><NameOfSubstance UI="D054465">Peroxiredoxin VI</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054465" MajorTopicYN="N">Peroxiredoxin VI</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020258" MajorTopicYN="Y">Neurotoxicity Syndromes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">A1 astrocyte</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Complement 3</Keyword><Keyword MajorTopicYN="N">Inflammatory cytokine</Keyword><Keyword MajorTopicYN="N">Peroxiredoxin 6</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>9</Day><Hour>12</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>9</Day><Hour>11</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37556038</ArticleId><ArticleId IdType="doi">10.1007/s11064-023-04003-w</ArticleId><ArticleId IdType="pii">10.1007/s11064-023-04003-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wijesekera LC, Leigh PN (2009) Amyotrophic lateral sclerosis. Orphanet J Rare Dis 4:3. https://doi.org/10.1186/1750-1172-4-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId><ArticleId IdType="pmc">2656493</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Sayana P, Zhang X, Le W (2013) Genetics of amyotrophic lateral sclerosis: an update. Mol Neurodegener 8:28. https://doi.org/10.1186/1750-1326-8-28</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-28</ArticleId><ArticleId IdType="pubmed">23941283</ArticleId><ArticleId IdType="pmc">3766231</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Wang F (2017) Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications. Front Immunol 8:1005. https://doi.org/10.3389/fimmu.2017.01005</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01005</ArticleId><ArticleId IdType="pubmed">28871262</ArticleId><ArticleId IdType="pmc">5567007</ArticleId></ArticleIdList></Reference><Reference><Citation>Komine O, Yamanaka K (2015) Neuroinflammation in motor neuron disease. Nagoya J Med Sci 77:537&#x2013;549</Citation><ArticleIdList><ArticleId IdType="pubmed">26663933</ArticleId><ArticleId IdType="pmc">4664586</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, M&#xfc;nch AE, Chung WS, Peterson TC, Wilton DK, Frouin A, Napier BA, Panicker N, Kumar M, Buckwalter MS, Rowitch DH, Dawson VL, Dawson TM, Stevens B, Barres BA (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541:481&#x2013;487. https://doi.org/10.1038/nature21029</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId><ArticleId IdType="pmc">5404890</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttenplan KA, Weigel MK, Adler DI, Couthouis J, Liddelow SA, Gitler AD, Barres BA (2020) Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model. Nat Commun 11:3753. https://doi.org/10.1038/s41467-020-17514-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17514-9</ArticleId><ArticleId IdType="pubmed">32719333</ArticleId><ArticleId IdType="pmc">7385161</ArticleId></ArticleIdList></Reference><Reference><Citation>Izrael M, Slutsky SG, Revel M (2020) Rising stars: astrocytes as a therapeutic target for ALS disease. Front Neurosci 14:824. https://doi.org/10.3389/fnins.2020.00824</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00824</ArticleId><ArticleId IdType="pubmed">32848579</ArticleId><ArticleId IdType="pmc">7399224</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall A, Nelson K, Poole LB, Karplus PA (2011) Structure-based insights into the catalytic power and conformational dexterity of peroxiredoxins. Antioxid Redox Signal 15:795&#x2013;815. https://doi.org/10.1089/ars.2010.3624</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2010.3624</ArticleId><ArticleId IdType="pubmed">20969484</ArticleId><ArticleId IdType="pmc">3125576</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YJ (2020) Knockout mouse models for peroxiredoxins. Antioxid (Basel) 9:182. https://doi.org/10.3390/antiox9020182</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9020182</ArticleId></ArticleIdList></Reference><Reference><Citation>Szeliga M (2020) Peroxiredoxins in neurodegenerative diseases. Antioxid (Basel) 9:1203. https://doi.org/10.3390/antiox9121203</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9121203</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher AB (2019) Antioxidants special issue: peroxiredoxin 6 as a unique member of the peroxiredoxin family. Antioxid (Basel) 8:107. https://doi.org/10.3390/antiox8040107</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox8040107</ArticleId></ArticleIdList></Reference><Reference><Citation>Arevalo JA, V&#xe1;zquez-Medina JP (2018) The role of peroxiredoxin 6 in cell signaling. Antioxid (Basel) 7:172. https://doi.org/10.3390/antiox7120172</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox7120172</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong L, McCoy M, Komuro H, West XZ, Yakubenko V, Gao D, Dudiki T, Milo A, Chen J, Podrez EA, Trapp B, Byzova TV (2022) Inflammation-dependent oxidative stress metabolites as a hallmark of amyotrophic lateral sclerosis. Free Radic Biol Med 178:125&#x2013;133. https://doi.org/10.1016/j.freeradbiomed.2021.11.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2021.11.031</ArticleId><ArticleId IdType="pubmed">34871763</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasai A, Kinjo T, Ishihara R, Sakai I, Ishimaru Y, Yoshioka Y, Yamamuro A, Ishige K, Ito Y, Maeda S (2011) Apelin deficiency accelerates the progression of amyotrophic lateral sclerosis. PLoS ONE 6:e23968. https://doi.org/10.1371/journal.pone.0023968</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023968</ArticleId><ArticleId IdType="pubmed">21887354</ArticleId><ArticleId IdType="pmc">3161091</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshioka Y, Sugino Y, Shibagaki F, Yamamuro A, Ishimaru Y, Maeda S (2020) Dopamine attenuates lipopolysaccharide-induced expression of proinflammatory cytokines by inhibiting the nuclear translocation of NF-&#x3ba;B p65 through the formation of dopamine quinone in microglia. Eur J Pharmacol 866:172826. https://doi.org/10.1016/j.ejphar.2019.172826</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2019.172826</ArticleId><ArticleId IdType="pubmed">31790652</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamuro A, Kishino T, Ohshima Y, Yoshioka Y, Kimura T, Kasai A, Maeda S (2011) Caspase-4 directly activates caspase-9 in endoplasmic reticulum stress-induced apoptosis in SH-SY5Y cells. J Pharmacol Sci 115:239&#x2013;243. https://doi.org/10.1254/jphs.10217SC</Citation><ArticleIdList><ArticleId IdType="doi">10.1254/jphs.10217SC</ArticleId><ArticleId IdType="pubmed">21282934</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner BJ, Talbot K (2008) Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog Neurobiol 85:94&#x2013;134. https://doi.org/10.1016/j.pneurobio.2008.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2008.01.001</ArticleId><ArticleId IdType="pubmed">18282652</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves CJ, de Santana LP, dos Santos AJ, de Oliveira GP, Duobles T, Scorisa JM, Martins RS, Maximino JR, Chadi G (2011) Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome. Brain Res 1394:90&#x2013;104. https://doi.org/10.1016/j.brainres.2011.02.060</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2011.02.060</ArticleId><ArticleId IdType="pubmed">21354109</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Oudart H, Ren&#xe9; F, Gonzalez de Aguilar JL, Loeffler JP (2004) Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci USA 101:11159&#x2013;11164. https://doi.org/10.1073/pnas.0402026101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId><ArticleId IdType="pmc">503756</ArticleId></ArticleIdList></Reference><Reference><Citation>Koza LA, Winter AN, Holsopple J, Baybayon-Grandgeorge AN, Pena C, Olson JR, Mazzarino RC, Patterson D, Linseman DA (2020) Protocatechuic acid extends survival, improves motor function, diminishes gliosis, and sustains neuromuscular junctions in the hSOD1G93A mouse model of amyotrophic lateral sclerosis. Nutrients 12:1824. https://doi.org/10.3390/nu12061824</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12061824</ArticleId><ArticleId IdType="pubmed">32570926</ArticleId><ArticleId IdType="pmc">7353311</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffer D, Cordera S, Cavalla P, Migheli A (1996) Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis. J Neurol Sci 139(Supplement):27&#x2013;33. https://doi.org/10.1016/0022-510x(96)00073-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510x(96)00073-1</ArticleId><ArticleId IdType="pubmed">8899654</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Q, Huo Y, Bai J, Wang H, Wang H, Yang F, Cui F, Song H, Huang X (2021) Inflammatory cytokine levels in patients with sporadic amyotrophic lateral sclerosis. Neurodegener Dis 21:87&#x2013;92. https://doi.org/10.1159/000522078</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000522078</ArticleId><ArticleId IdType="pubmed">35124669</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortelli R, Zecca C, Piccininni M, Benmahamed S, Dell&#x2019;Abate MT, Barulli MR, Capozzo R, Battista P, Logroscino G (2020) Plasma inflammatory cytokines are elevated in ALS. Front Neurol 11:552295. https://doi.org/10.3389/fneur.2020.552295</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.552295</ArticleId><ArticleId IdType="pubmed">33281700</ArticleId><ArticleId IdType="pmc">7691268</ArticleId></ArticleIdList></Reference><Reference><Citation>Kia A, McAvoy K, Krishnamurthy K, Trotti D, Pasinelli P (2018) Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha. Glia 66:1016&#x2013;1033. https://doi.org/10.1002/glia.23298</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23298</ArticleId><ArticleId IdType="pubmed">29380416</ArticleId><ArticleId IdType="pmc">5873384</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller SJ, Zhang PW, Glatzer J, Rothstein JD (2017) Astroglial transcriptome dysregulation in early disease of an ALS mutant SOD1 mouse model. J Neurogenet 31:37&#x2013;48. https://doi.org/10.1080/01677063.2016.1260128</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01677063.2016.1260128</ArticleId><ArticleId IdType="pubmed">28019127</ArticleId></ArticleIdList></Reference><Reference><Citation>Drachman DB, Frank K, Dykes-Hoberg M, Teismann P, Almer G, Przedborski S, Rothstein JD (2002) Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann Neurol 52:771&#x2013;778. https://doi.org/10.1002/ana.10374</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10374</ArticleId><ArticleId IdType="pubmed">12447931</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomonov Y, Hadad N, Levy R (2016) Reduction of cytosolic phospholipase A2&#x3b1; upregulation delays the onset of symptoms in SOD1G93A mouse model of amyotrophic lateral sclerosis. J Neuroinflammation 13:134. https://doi.org/10.1186/s12974-016-0602-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0602-y</ArticleId><ArticleId IdType="pubmed">27250836</ArticleId><ArticleId IdType="pmc">4888471</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhunchha B, Fatma N, Kubo E, Rai P, Singh SP, Singh DP (2013) Curcumin abates hypoxia-induced oxidative stress based-ER stress-mediated cell death in mouse hippocampal cells (HT22) by controlling Prdx6 and NF-&#x3ba;B regulation. Am J Physiol Cell Physiol 304:C636&#x2013;C655. https://doi.org/10.1152/ajpcell.00345.2012</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00345.2012</ArticleId><ArticleId IdType="pubmed">23364261</ArticleId><ArticleId IdType="pmc">3625714</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Ji P, Zhang L, Bu G, Gu H, Wang X, Xiong Y, Zuo B (2015) The expression of porcine Prdx6 gene is up-regulated by C/EBP &#x3b2; and CREB. PLoS ONE 10:e0144851. https://doi.org/10.1371/journal.pone.0144851</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0144851</ArticleId><ArticleId IdType="pubmed">26659441</ArticleId><ArticleId IdType="pmc">4699452</ArticleId></ArticleIdList></Reference><Reference><Citation>Meir O, Dvash E, Werman A, Rubinstein M (2010) C/EBP-beta regulates endoplasmic reticulum stress-triggered cell death in mouse and human models. PLoS ONE 5:e9516. https://doi.org/10.1371/journal.pone.0009516</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009516</ArticleId><ArticleId IdType="pubmed">20209087</ArticleId><ArticleId IdType="pmc">2831074</ArticleId></ArticleIdList></Reference><Reference><Citation>Brasil AA, de Carvalho MDC, Gerhardt E, Queiroz DD, Pereira MD, Outeiro TF, Eleutherio ECA (2019) Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant SOD1. Proc Natl Acad Sci USA 116:25991&#x2013;26000. https://doi.org/10.1073/pnas.1902483116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1902483116</ArticleId><ArticleId IdType="pubmed">31796595</ArticleId><ArticleId IdType="pmc">6926019</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalmar B, Lu CH, Greensmith L (2014) The role of heat shock proteins in amyotrophic lateral sclerosis: the therapeutic potential of arimoclomol. Pharmacol Ther 141:40&#x2013;54. https://doi.org/10.1016/j.pharmthera.2013.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2013.08.003</ArticleId><ArticleId IdType="pubmed">23978556</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng Y, Chattopadhyay M, Whitelegge J, Valentine JS (2012) SOD1 aggregation and ALS: role of metallation states and disulfide status. Curr Top Med Chem 12:2560&#x2013;2572. https://doi.org/10.2174/1568026611212220010</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026611212220010</ArticleId><ArticleId IdType="pubmed">23339308</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H, Matsuoka M (2012) TDP-43 toxicity is mediated by the unfolded protein response-unrelated induction of C/EBP homologous protein expression. J Neurosci Res 90:641&#x2013;647. https://doi.org/10.1002/jnr.22777</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.22777</ArticleId><ArticleId IdType="pubmed">22057717</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O, Bordoni M, Diamanti L, Sproviero D, Gagliardi S, Cereda C (2018) SOD1 in amyotrophic lateral sclerosis: &#x201c;ambivalent&#x201d; behavior connected to the disease. Int J Mol Sci 19:1345. https://doi.org/10.3390/ijms19051345</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051345</ArticleId><ArticleId IdType="pubmed">29751510</ArticleId><ArticleId IdType="pmc">5983710</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Durazo A, Whitelegge JP, Borchelt DR (2010) An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1. Hum Mol Genet 19:4774&#x2013;4789. https://doi.org/10.1093/hmg/ddq408</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq408</ArticleId><ArticleId IdType="pubmed">20871097</ArticleId><ArticleId IdType="pmc">2989888</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>